Morgan Stanley's big prediction: Alphabet Inc. Class C's cloud revenue (GOOGL.US) in 2026 may surge by over 50%
Google Cloud (GOOGL.US) is expected to experience explosive growth next year, according to analysts at Morgan Stanley. The department's revenue growth in 2026 may exceed 50%.
Alphabet Inc. Class C cloud (GOOGL.US) is expected to experience a growth explosion next year, with Morgan Stanley analysts predicting that the department's revenue growth in 2026 may exceed 50%.
In a recent report, Morgan Stanley analyst Brian Nowak told investors that the bank's updated backlog model "outlines a path for Alphabet Inc. Class C cloud revenue to grow over 50% in 2026," which means "there is a mid-teens upward adjustment compared to our previous expectations and over 15% upward adjustment compared to market consensus."
Nowak pointed out that the bank still sees Alphabet Inc. Class C cloud as "a core driver of Alphabet's valuation multiple expansion and AI-driven outperformance."
The new model of the bank breaks down Alphabet Inc. Class C cloud revenue into backlog contribution and on-demand workloads contribution.
The company recently disclosed that "approximately 55% of the $158 billion backlog in the third quarter of 2025 is expected to be recognized as revenue in the next two years."
Historically, these backlog orders typically contribute "45%-50% of Alphabet Inc. Class C cloud revenue," with the remaining coming from on-demand workloads. Morgan Stanley stated that on-demand business "grew by 29%/37% year-over-year in 2023/2024" and "increased by approximately 25% since the beginning of 2025."
Based on these trends, Morgan Stanley's sensitivity analysis shows that if Alphabet Inc. Class C cloud saw a "net addition of backlog orders exceeding $50 billion in 2026," and on-demand business grows by 15% or more, the total revenue growth of the cloud business could exceed by 50%.
Nowak mentioned that even under more conservative assumptions "on-demand business grows by 25% year-over-year" and "backlog orders increase by $20 billion," the model still supports expectations of over 50% growth.
Related Articles

WEIGAO GROUP (01066) spent HK$1.8368 million on November 6 to repurchase 340,000 shares.

COSCO Shipping Holdings (01919) spent approximately HK$20.98 million on November 6th to repurchase 1.53 million shares.

Shanghai Pharmaceuticals Holding (601607.SH): Tofacitinib Citrate Extended-Release Tablets Approved for Production.
WEIGAO GROUP (01066) spent HK$1.8368 million on November 6 to repurchase 340,000 shares.

COSCO Shipping Holdings (01919) spent approximately HK$20.98 million on November 6th to repurchase 1.53 million shares.

Shanghai Pharmaceuticals Holding (601607.SH): Tofacitinib Citrate Extended-Release Tablets Approved for Production.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


